SCHEMBL5850552

SCHEMBL5850552

CCc1cc2c(N3CCN(C(=O)OC(C)(C)C)CC3)ncnc2s1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 6/20 0.68
MEN1 O00255 11/20 0.66
HRH4 Q9H3N8 1/20 0.63
KMT2A Q03164 6/20 0.62
ALDH1A1 P00352 3/20 0.62
HTT P42858 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.60
TSHR P16473 2/20 0.60
KDM4E B2RXH2 1/20 0.60
LMNA P02545 1/20 0.60
TP53 P04637 1/20 0.58
MAPT P10636 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
ALOX15 P16050 1/20 0.55
MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5849427 0.92 P2RY12 (0.57) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5849430 0.92 P2RY12 (0.58) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5849216 0.90 P2RY12 (0.55) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5849326 0.89 P2RY12 (0.55) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5849479 0.89 P2RY12 (0.62) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL19687734 0.88 P2RY12 (0.56) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5850680 0.88 MEN1 (0.70) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5850685 0.87 P2RY12 (0.55) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5849244 0.86 MEN1 (0.60) P2RY12MEN1HRH4KMT2AALDH1A1
SCHEMBL5849270 0.86 P2RY12 (0.62) P2RY12MEN1HRH4KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115741-B2 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds ALEXION PHARMACEUTICALS, INC. 2006-10-03 US disclosed
WO-2003022214-A2 PIPERAZINE AND HOMOPIPERAZINE COMPOUNDS MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-03-20 WO disclosed